1. Home
  2. VIR vs MEG Comparison

VIR vs MEG Comparison

Compare VIR & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.07

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$21.80

Market Cap

930.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
MEG
Founded
2016
2012
Country
United States
United States
Employees
N/A
3500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
930.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
VIR
MEG
Price
$9.07
$21.80
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
$19.63
$35.25
AVG Volume (30 Days)
4.4M
422.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
17.49
93.69
EPS
N/A
N/A
Revenue
$68,556,000.00
$830,538,000.00
Revenue This Year
N/A
$5.46
Revenue Next Year
$1,049.62
$7.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.26
52 Week Low
$4.16
$10.51
52 Week High
$10.91
$32.00

Technical Indicators

Market Signals
Indicator
VIR
MEG
Relative Strength Index (RSI) 52.15 35.09
Support Level $8.67 $21.00
Resistance Level $10.29 $24.03
Average True Range (ATR) 0.52 1.19
MACD -0.12 -0.63
Stochastic Oscillator 24.69 1.40

Price Performance

Historical Comparison
VIR
MEG

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

Share on Social Networks: